Scientists have developed several pharmaceutical and non-pharmaceutical interventions to contain the current coronavirus disease 2019 (COVID-19) pandemic, which is caused by the rapid outbreak of...
The coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, resulted in devastating mortality and an enormous number of...
Scientists at Northwestern Medicine are using new advances in CRISPR gene-editing technology to uncover new biology that could lead to longer-lasting treatments and new therapeutic...
A recent study posted to the medRxiv* preprint server investigated the effect of low circulating seasonal influenza virus during the severe acute respiratory syndrome coronavirus...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected through the coronavirus disease 2019 (COVID-19) that it caused, in Wuhan, China, at the...
For the last seven years, researchers at the Lewis Katz School of Medicine at Temple University have been developing and refining CRISPR-based gene-editing technology for...
The concentration of the proteins S100A8 and S100A9 in serum increases during an inflammatory response. Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome encodes for four structural proteins, of which include the nucleocapsid (N), spike (S), membrane (M), and...
Individuals with low immunoglobulin levels and reduced antibody responses to pathogens and vaccines are associated with common variable immune deficiency (CVID) and other primary antibody...
Twenty years’ worth of surveys suggest that nearly one in ten sexually active men in 35 countries in sub-Saharan Africa have been clients of sex...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce...
New research establishes the potent activity of turmeric root and its bioactive compound curcumin against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The researchers...
